Pharmaceutical - Eisai

Filter

Current filters:

Eisai

Popular Filters

6715 to 6739 of 6822 results

Top donor countries oppose crucial treatment target ahead of UN AIDS Summit, says MSF

12-05-2011

A report released yesterday by the international medical humanitarian organization Medecins Sans Frontieres…

Anti-viralsFinancialHealthcarePharmaceutical

Broadside against US government as Lauren Stevens case is dismissed

12-05-2011

In a stunning ruling this week, US District Court Judge Roger Titus ruled from the bench in Greenbelt,…

GlaxoSmithKlineLegalPharmaceutical

EU Parliament’s stand against conflicts of interest: is it enough to ensure medicines safety? ask consumer groups

12-05-2011

Consumer action groups Health Action International (HAI) Europe, Medicines in Europe Forum (MiEF) and…

EuropePharmaceuticalRegulation

Mayo Clinic researchers find new treatment for constipation

12-05-2011

Constipation is definitely not a glamorous topic. In reality, it affects nearly 30 million Americans…

Gastro-intestinalsPharmaceuticalResearch

US concerns about bias in commercially funded continuing medical education

12-05-2011

Commercial funding of continuing medical education (CME) and the potential for bias appear to concern…

North AmericaPharmaceuticalResearch

Takeda takes stake in USA-based Fate Therapeutics to expand in regenerative medicines

11-05-2011

Japan’s largest drugmaker Takeda Pharmaceutical (TSE: 4502) has made an equity investment in privately-held…

BiotechnologyFate TherapeuticsMergers & AcquisitionsPharmaceuticalTakeda Pharmaceuticals

Novartis’ Votubia cleared as first drug in Switzerland for SEGA

11-05-2011

Swissmedic, the Swiss drug regulation agency, has approved domestic drug major Novartis’ (NOVN:…

EuropeeverolimusNovartisOncologyPharmaceuticalRare diseasesRegulationVotubia

Despite boost to Australia mental health funding, latest schizophrenia drug still blocked

11-05-2011

As part of its latest budget announcement, Australia’s federal government has allocated A$2.2 billion…

HealthcareNeurologicalPharmaceuticalPoliticsPrevnarPricingVaccines

Almirall 1st-qtr 2011 financial results impacted by health reforms

11-05-2011

Spain’s largest drugmaker Almirall (ALM: MC) yesterday announced results for the first quarter of…

AlmirallFinancialPharmaceutical

New health systems directorate in EU’s DG SANCO

11-05-2011

The European Commission Directorate in charge of health and consumers has been reorganized, with the…

EuropeHealthcareManagementPharmaceutical

US FDA consults on user fee program for biosimilar and interchangeable biologicals

10-05-2011

The US Food and Drug Administration is requesting input from stakeholders and the public relating to…

BiotechnologyGenericsNorth AmericaPharmaceuticalRegulation

AstraZeneca achieves three significant milestones for blood thinner Brilique

10-05-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) yesterday announced three items of news regarding its…

AstraZenecaBrilintaBriliqueCardio-vascularEuropePharmaceuticalPricingRegulationResearch

Pfizer’s Prevnar 13 meets all endpoints in pivotal Ph III trials on over 50s

10-05-2011

Global drugs behemoth Pfizer (NYSE: PFE) says that the data from its two pivotal Phase III immunogenicity…

PfizerPharmaceuticalPrevnarResearchRespiratory and PulmonaryVaccines

Shionogi posts strong fiscal year 2011 results; shows efficacy of Kapvay ER

10-05-2011

Japanese drug major Shionogi (TKO: 4507) reported its unconsolidated fiscal year 2011 (ended March) results…

FinancialKapvayNeurologicalPharmaceuticalResearchShionogi

Short-term use of some NSAIDs could be dangerous to heart attack survivors

10-05-2011

Even short-term use of some painkillers could be dangerous for people who have had a heart attack, increasing…

PharmaceuticalResearch

Shire gets exclusive option for Heptares A2A program for CNS diseases

10-05-2011

Closely-held UK-based drug discovery firm Heptares Therapeutics says it has signed an exclusive option…

Heptares TherapeuticsLicensingNeurologicalPharmaceuticalShire

Neurotechnology revenues near $150 billion, according to NeuroInsights

10-05-2011

The global neurotechnology industry grew to a value of $149.8 billion in 2010, up 3.2% on the previous…

BiotechnologyMarkets & MarketingNeurologicalPharmaceutical

New resource helps pharma comply with latest ABPI disclosure regulations

10-05-2011

A new internet resource called Pharma Disclosure, http://www.pharma-disclosure.co.uk, launched this month,…

EuropePharmaceuticalRegulation

Elan Drug Tech to merge into Alkermes in $960 million deal to create CNS leader

09-05-2011

US drugmaker Alkermes (Nasdaq: ALKS) and Ireland-based Elan Corp (NYSE: ELN) revealed this morning that…

AlkermesElanElan Drug TechnologiesMergers & AcquisitionsNeurologicalPharmaceutical

Sanofi-Aventis pulls out of diabetes accord with Metabolex; enters deal for malaria drugs; shortens name

09-05-2011

French drug major Sanofi-Aventis (Euronext: SAN) has pulled out of a drug development deal with California,…

DiabetesLicensingMetabolexPharmaceuticalSanofi-AventisTropical diseases

6715 to 6739 of 6822 results

Company Spotlight

Fibrotech

Fibrotech

Back to top